• No results found

Neutropeniacausedbyhairycellleukemiainapatientwithmyelofibrosissecondarytopolycythemiavera:acasereport CASEREPORTOpenAccess

N/A
N/A
Protected

Academic year: 2022

Share "Neutropeniacausedbyhairycellleukemiainapatientwithmyelofibrosissecondarytopolycythemiavera:acasereport CASEREPORTOpenAccess"

Copied!
6
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for

High dose chemotherapy with autologous stem cell transplantation (HDT-ASCT).. Stem cell

Relapse-free survival (RFS) and overall survival (OS) in patients positive for FMS-like tyrosine kinase 3 – internal tandem duplication acute myeloid leukemia in complete

AD autoimmune disorders, ALL acute lymphoblastic leukaemia, Allo allogeneic transplantation, AML acute myeloid leukaemia, Auto autologous transplantation, CML chronic

Four cases of BK virus-associated Hemorrhagic Cystitis (HC) in an allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) setting are reported, including –for the first

Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis. Curr Treat

In 2014 we introduced anti-thymocyte globulin (ATG) to the graft-versus-host disease (GvHD) prophylaxis regimen in allogeneic stem cell transplantation (Allo-HSCT) with peripheral

Results of a phase 1 study of quizartinib (AC220) as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic cell